These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27907224)

  • 1. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Scott A
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002007. PubMed ID: 27907224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
    Holland P; Jahnke N
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD002007. PubMed ID: 34159577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Jahnke N
    Cochrane Database Syst Rev; 2014 Apr; (4):CD002007. PubMed ID: 24788768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Tan A
    Cochrane Database Syst Rev; 2005 Apr; (2):CD002007. PubMed ID: 15846627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
    Elphick HE; Tan A
    Cochrane Database Syst Rev; 2001; (1):CD002007. PubMed ID: 11279745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2013 Oct; (10):CD005405. PubMed ID: 24170644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J; Nevitt SJ
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Bhatt J; Jahnke N; Smyth AR
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.
    Breen L; Aswani N
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD002767. PubMed ID: 22786481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Smith S; Rowbotham NJ; Charbek E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2014 Feb; (2):CD002009. PubMed ID: 24497229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Abbott L; Plummer A; Hoo ZH; Wildman M
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006682. PubMed ID: 31487382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Tan KH
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.